Literature DB >> 17359501

Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme.

T Kin1, X Zhai, T B Murdoch, A Salam, A M James Shapiro, Jonathan R T Lakey.   

Abstract

A major obstacle to successful human islet isolation has been the variability of the enzymatic digestion phase. The aim of this study was to define optimal enzyme activity ranges normalized by the pancreas weight and to identify valid parameters for the optimal selection of successful lots of collagenase enzyme blends. Our results from 251 islet isolations showed that optimization of thermolysin dosage based on Caseinase unit/g pancreas contributed considerably to islet isolation outcome but that collagenase dosage measured by the manufacturer (Wünsch unit/g pancreas) was not a major determinant of islet isolation outcome. We also found that lot-to-lot inconsistency of enzyme performance was not explained by the activity values provided by the manufacturer, but rather by an in-house assay of class I collagenase (CI) and class II collagenase (CII); using a lot with a lower CII/CI resulted in a higher success rate. The odds of successful isolation was 8.67 times higher when a vial with CII/CI ratio <0.204 was used than when a vial with CII/CI >or=0.204 was used, suggesting that CII/CI ratio may be a strong predictor to distinguish potential lot success. This study provides a framework for improved enzymatic digestion in human islet isolation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359501     DOI: 10.1111/j.1600-6143.2007.01760.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  23 in total

1.  Improvement of collagenase distribution with the ductal preservation for human islet isolation.

Authors:  Masayuki Shimoda; Takeshi Itoh; Koji Sugimoto; Shuichi Iwahashi; Morihito Takita; Daisuke Chujo; Jeffery A Sorelle; Bashoo Naziruddin; Marlon F Levy; Paul A Grayburn; Shinichi Matsumoto
Journal:  Islets       Date:  2012-03-01       Impact factor: 2.694

2.  Experience of islet isolation without neutral protease supplementation.

Authors:  Tatsuya Kin; Doug O'Gorman; Peter Senior; A M James Shapiro
Journal:  Islets       Date:  2010-09-01       Impact factor: 2.694

3.  A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products.

Authors:  A N Balamurugan; Gopalakrishnan Loganathan; Melena D Bellin; Joshua J Wilhelm; James Harmon; Takayuki Anazawa; Sajjad M Soltani; David M Radosevich; Takeshi Yuasa; Mukesh Tiwari; Klearchos K Papas; Robert McCarthy; David E R Sutherland; Bernhard J Hering
Journal:  Transplantation       Date:  2012-04-15       Impact factor: 4.939

4.  Update on islet cell transplantation for type 1 diabetes.

Authors:  Avinash Agarwal; Kenneth L Brayman
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

5.  Different digestion enzymes used for human pancreatic islet isolation: a mixed treatment comparison (MTC) meta-analysis.

Authors:  Jakeline Rheinheimer; Patrícia Klarmann Ziegelmann; Rodrigo Carlessi; Luciana Ross Reck; Andrea Carla Bauer; Cristiane Bauermann Leitão; Daisy Crispim
Journal:  Islets       Date:  2014-11-07       Impact factor: 2.694

6.  Evaluation of viable β-cell mass is useful for selecting collagenase for human islet isolation: comparison of collagenase NB1 and liberase HI.

Authors:  R Misawa; C Ricordi; A Miki; S Barker; R D Molano; A Khan; S Miyagawa; L Inverardi; R Alejandro; A Pileggi; H Ichii
Journal:  Cell Transplant       Date:  2011-09-16       Impact factor: 4.064

Review 7.  Tissue dissociation enzymes for isolating human islets for transplantation: factors to consider in setting enzyme acceptance criteria.

Authors:  Robert C McCarthy; Andrew G Breite; Michael L Green; Francis E Dwulet
Journal:  Transplantation       Date:  2011-01-27       Impact factor: 4.939

8.  Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes.

Authors:  J S Kaddis; J S Danobeitia; J C Niland; T Stiller; L A Fernandez
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

9.  Caspase inhibitor therapy synergizes with costimulation blockade to promote indefinite islet allograft survival.

Authors:  Juliet A Emamaullee; Joy Davis; Rena Pawlick; Christian Toso; Shaheed Merani; Sui-Xiong Cai; Ben Tseng; A M James Shapiro
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

10.  Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation.

Authors:  Appakalai N Balamurugan; Michael L Green; Andrew G Breite; Gopalakrishnan Loganathan; Joshua J Wilhelm; Benjamin Tweed; Lenka Vargova; Amber Lockridge; Manikya Kuriti; Michael G Hughes; Stuart K Williams; Bernhard J Hering; Francis E Dwulet; Robert C McCarthy
Journal:  Transplant Direct       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.